Apoptosis

, Volume 16, Issue 9, pp 950–958

Elevated transcription of the p53 gene in early S-phase leads to a rapid DNA-damage response during S-phase of the cell cycle

Original Paper

Abstract

p53 induces the transcription of genes that negatively regulate progression of the cell cycle in response to DNA damage or other cellular stressors, and thus participates in maintaining genome stability. Under stress conditions, p53 must be activated to prohibit the replication of cells containing damaged DNA. However, in normal, non-stressed cells, p53 activity must be inhibited. Previous studies have demonstrated that p53 transcription is activated before or during early S-phase in cells progressing from G0/G1 into S-phase. Since this is not what would be predicted from a gene involved in growth arrest and apoptosis, in this study, we provide evidence that this induction occurs to provide sufficient p53 mRNA to ensure a rapid response to DNA damage before exiting S-phase. When comparing exponentially growing Swiss3T3 cells to those synchronized to enter S-phase simultaneously and treated with the DNA damaging agent camptothecin, we found that with cells in S-phase, p53 protein levels increased earlier, Bax and p21 transcription was activated earlier and to a greater extent and apoptosis occurred earlier and to a greater extent. These findings are consistent with p53 transcription being induced in S-phase to provide for a rapid DNA-damage response during S-phase of the cell cycle.

Keywords

p53 DNA damage Checkpoints S-phase Apoptosis 

References

  1. 1.
    Horn HF, Vousden KH (2007) Coping with stress: multiple ways to activate p53. Oncogene 26:1306–1316PubMedCrossRefGoogle Scholar
  2. 2.
    Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137:413–431PubMedCrossRefGoogle Scholar
  3. 3.
    Agarwal ML, Agarwal A, Taylor WR, Chernova O, Sharma Y, Stark GR (1998) A p53- dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc Natl Acad Sci USA 95:14775–14780PubMedCrossRefGoogle Scholar
  4. 4.
    Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358:15–16PubMedCrossRefGoogle Scholar
  5. 5.
    Attardi LD, Jacks T (1999) The role of p53 in tumour suppression: lessons from mouse models. Cell Mol Life Sci 55:48–63PubMedCrossRefGoogle Scholar
  6. 6.
    Reich NC, Levine AJ (1984) Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature 308:199–201PubMedCrossRefGoogle Scholar
  7. 7.
    Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W (1995) Negative feedback regulation of wild-type p53 biosynthesis. EMBO J 14:4442–4449PubMedGoogle Scholar
  8. 8.
    Oren M, Rotter V (1999) Introduction: p53–the first twenty years. Cell Mol Life Sci 5:9–11CrossRefGoogle Scholar
  9. 9.
    Barak Y, Juven T, Haffner R, Oren M (1993) mdm2 expression is induced by wild type p53 activity. EMBO J 12:461–468PubMedGoogle Scholar
  10. 10.
    Fang S, Jensen JP, Ludwig RL, Vousden KH, Weissman AM (2000) Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem 275:8945–8951PubMedCrossRefGoogle Scholar
  11. 11.
    Yee KS, Vousden KH (2005) Complicating the complexity of p53. Carcinogenesis 26:1317–1322PubMedCrossRefGoogle Scholar
  12. 12.
    Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311PubMedGoogle Scholar
  13. 13.
    Menendez D, Inga A, Resnick MA (2009) The expanding universe of p53 targets. Nat Rev Cancer 10:724–737CrossRefGoogle Scholar
  14. 14.
    Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139:1281–1292PubMedCrossRefGoogle Scholar
  15. 15.
    Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47–59PubMedCrossRefGoogle Scholar
  16. 16.
    Gottifredi V, McKinney K, Poyurovsky MV, Prives C (2004) Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block. J Biol Chem 279:5802–5810PubMedCrossRefGoogle Scholar
  17. 17.
    Janus F, Albrechtsen N, Dornreiter I, Wiesmüller L, Grosse F, Deppert W (1999) The dual role model for p53 in maintaining genomic integrity. Cell Mol Life Sci 55:12–27PubMedCrossRefGoogle Scholar
  18. 18.
    Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20:1803–1815PubMedCrossRefGoogle Scholar
  19. 19.
    Reed JC, Alpers JD, Nowell PC, Hoover RG (1986) Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Proc Natl Acad Sci USA 83:3982–3986PubMedCrossRefGoogle Scholar
  20. 20.
    Ginsberg D, Oren M, Yaniv M, Piette J (1990) Protein-binding elements in the promoter region of the mouse p53 gene. Oncogene 5:1285–1290PubMedGoogle Scholar
  21. 21.
    Boggs K, Reisman D (2006) Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter. Oncogene 25:555–565PubMedGoogle Scholar
  22. 22.
    Horwitz SB, Chang CK, Grollman AP (1971) Studies on camptothecin: I. Effects on nucleic acid and protein synthesis. Mol Pharmacol 7:632–644PubMedGoogle Scholar
  23. 23.
    Hsiang YH, Hertzberg R, Hecht S, Liu LF (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873–14878PubMedGoogle Scholar
  24. 24.
    Mei Y, Xie C, Xie W, Tian X, Li M, Wu M (2007) Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis. Neoplasia 9:871–881PubMedCrossRefGoogle Scholar
  25. 25.
    Fink R, Fink K (1962) Utilization of radiocarbon from thymidine and other precursors of ribonucleic acid in Neurospora crassa. J Biol Chem 237:2289–2290PubMedGoogle Scholar
  26. 26.
    Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A et al (2001) Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem 276:15164–15173PubMedCrossRefGoogle Scholar
  27. 27.
    Boggs K, Reisman D (2007) The transcription factor C/EBP is essential for cell cycle regulation of the p53 gene. J. Biol. Chem. 282:7982–7990PubMedCrossRefGoogle Scholar
  28. 28.
    Polson A, Takahashi P, Reisman D (2010) Chromatin Immunoprecipitation (ChIP) Analysis Demonstrates Coordinated Binding of Two Transcription Factors to the Promoter of the p53 Tumor Suppressor Gene. Cell Biol Int 34:883–891PubMedCrossRefGoogle Scholar
  29. 29.
    Offer H et al (2001) p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress. Cancer Res 61:88–96PubMedGoogle Scholar
  30. 30.
    Jin S, Levine AJ (2001) The p53 functional circuit. J Cell Sci 114:4139–4140PubMedGoogle Scholar
  31. 31.
    Firlej V, Bocquet B, Desbiens X, de Launoit Y, Chotteau-Lelièvre A (2005) Pea3 transcription factor cooperates with USF-1 in regulation of the murine bax transcription without binding to an Ets-binding site. J Biol Chem 280:887–898PubMedCrossRefGoogle Scholar
  32. 32.
    Gottifredi V, Shieh S, Taya Y, Prives C (2001) p53 accumulates but is functionally impaired when DNA synthesis is blocked. Proc Natl Acad Sci USA 98:1036–1041PubMedCrossRefGoogle Scholar
  33. 33.
    Zhang XP, Lui F, Wang W (2010) Coordination between cell cycle progression and cell fate decision by the p53 and E2F1 pathways in response to DNA damage. J Biol Chem 285:31571–31580PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Paula Takahashi
    • 1
    • 2
  • Amanda Polson
    • 1
  • David Reisman
    • 1
  1. 1.Department of Biological SciencesUniversity of South CarolinaColumbiaUSA
  2. 2.Departamento de Genética, Faculdade de Medicina de Ribeirão PretoUniversidade de São PauloRibeirão PretoBrazil

Personalised recommendations